🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +9.62% on $8795.T in just 0m.
TTO
$TTOO
🔒 US EquitiesT2 Biosystems Inc
AVG HISTORICAL GAP
+1.66%
MAX GAP RECORD
+7.67%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $TTOO
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$TTOO
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Jun 11, 2025 Earnings Release 2025-06-11 (AFTER CLOSE) |
+7.67%
|
| Nov 14, 2024 Earnings Release 2024-11-14 (UNDETERMINED) |
+0.00%
|
| Jul 29, 2024 Earnings Release 2024-07-29 (AFTER CLOSE) |
+1.90%
|
| May 07, 2024 Earnings Release 2024-05-07 (AFTER CLOSE) |
+2.16%
|
| Nov 15, 2023 Earnings Release 2023-11-15 (BEFORE OPEN) |
-1.35%
|
| Aug 07, 2023 Earnings Release 2023-08-07 (AFTER CLOSE) |
+4.21%
|
| May 22, 2023 Earnings Release 2023-05-22 (AFTER CLOSE) |
-6.29%
|
| Mar 13, 2023 Earnings Release 2023-03-13 (AFTER CLOSE) |
+3.29%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.8%
Bullish Gaps (5)
Bearish Gaps (2)
Neutral / Flat (0)
📖 Intelligence Summary
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗